Equities

Medical System Network Co Ltd

Medical System Network Co Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (JPY)570.00
  • Today's Change-16.00 / -2.73%
  • Shares traded53.50k
  • 1 Year change+52.82%
  • Beta1.0500
Data delayed at least 20 minutes, as of Jul 05 2024 07:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

MEDICAL SYSTEM NETWORK Co., Ltd. is mainly engaged in the operation of dispensing pharmacy business. The Company operates in five business segments. The Pharmaceutical Product Network segment involves in ordering system of medicines, development and sale of systems, and support services for securitized receivables. The Dispensing Pharmacy segment operates and manages dispensing pharmacies. The Leasing and Equipment-related Business segment involves in the location development of pharmacies, the rental of buildings for clinics, and the operation of buildings and housing for the elderly. The Food Supply segments provides food service within hospitals and welfare facilities. The Others segment involves in clinical trial support services and visiting nursing services.

  • Revenue in JPY (TTM)115.36bn
  • Net income in JPY1.86bn
  • Incorporated1999
  • Employees3.74k
  • Location
    Medical System Network Co Ltd6F, AKK Bldg.24-3, Kita-Jujo Nishi, Chuo-kuSAPPORO-SHI 060-0010JapanJPN
  • Phone+81 116121069
  • Fax+81 116121068
  • Websitehttps://www.msnw.co.jp/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
4350:TYO since
announced
Transaction
value
PharmaShift Co LtdDeal completed07 Nov 202307 Nov 2023Deal completed21.54%--
Data delayed at least 20 minutes, as of Jul 05 2024 07:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Sophia Holdings Co Ltd9.03bn-100.89m4.82bn193.00--1.5315.510.5342-22.92-22.922,981.75701.281.1811.297.2446,796,550.00-1.322.93-2.195.0937.3935.07-1.122.321.4312.750.44450.00-4.1414.77-577.93---12.58--
Satudora Holdings Co Ltd95.52bn470.00m11.59bn1.11k23.921.237.950.121334.0334.036,913.01659.282.176.6915.13--1.090.7972.151.4924.6624.390.50250.36310.440312.580.653142.429.192.45440.2374.56-5.881.39
Hyuga Primary Care Co Ltd8.29bn441.03m11.86bn544.0027.617.0718.791.4359.2659.261,110.52231.461.7934.906.2515,231,350.009.52--14.71--22.71--5.32--1.1291.550.6301--24.46--15.19------
Healthlead PCL7.64bn354.70m12.83bn484.0036.172.9520.611.680.29580.29586.373.631.265.65178.74--5.879.006.8211.2423.0522.774.645.463.0821.270.2055--7.64---36.84------
Sunshine Holdings PLC29.30bn2.36bn16.04bn1.70k6.801.614.410.54759.099.09112.8838.431.403.496.2832,609,450.0015.1512.8727.7823.7431.0429.6910.8410.291.0514.670.299116.937.0319.6597.4947.20-5.6948.41
Medical System Network Co Ltd115.36bn1.86bn17.47bn3.74k9.231.103.470.151461.7561.753,836.48519.081.7212.5030.1630,812,230.002.792.194.173.3541.5440.831.621.330.656313.490.657223.755.303.2715.5332.12-7.853.71
Charmacy Pharmaceutical Co Ltd97.35bn1.14bn19.11bn831.0016.831.4511.110.19630.51090.510943.815.951.446.054.885,694,516.001.681.798.287.996.346.081.171.240.77752.790.511137.095.472.27-43.252.48-16.010.0027
Dingdang Health Technology Group Ltd107.37bn-4.99bn28.98bn2.62k--0.6433--0.2699-0.1813-0.18133.901.631.535.4844.371,995,840.00-7.26-55.91-10.34-82.5131.1032.74-4.75-35.831.93--0.0644--12.1952.7292.03--13.40--
Kimia Farma Tbk PT100.69bn-15.31bn35.45bn11.18k--0.6367--0.3521-278.91-285.741,832.811,013.040.54332.494.98889,725,100.00-10.39-1.82-21.12-3.2228.0235.14-19.12-3.080.3249-2.700.5505--7.933.33-737.71---9.87--
JZJ Chain Drugstore Corp204.07bn8.63bn86.06bn16.65k9.951.33--0.42172.532.5359.7218.890.94572.5117.64554,255.804.015.757.3811.1735.8335.214.245.040.3124.420.618636.6220.8426.8410.7225.4123.62--
Genky DrugStores Co Ltd181.44bn5.91bn86.08bn1.75k14.301.887.620.4744194.27194.275,966.931,474.471.746.6951.56103,503,100.005.684.618.637.4020.3121.183.262.810.34992.800.41369.769.3212.257.778.8513.4214.87
Data as of Jul 05 2024. Currency figures normalised to Medical System Network Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

14.45%Per cent of shares held by top holders
HolderShares% Held
Samarang LLPas of 15 Jun 20231.79m5.85%
Nomura Asset Management Co., Ltd.as of 31 May 2024739.00k2.41%
SPARX Asset Management Co., Ltd.as of 27 Mar 2023476.20k1.55%
Dimensional Fund Advisors LPas of 06 Jun 2024409.00k1.34%
Nikko Asset Management Co., Ltd.as of 07 Jun 2024402.20k1.31%
Daiwa Asset Management Co. Ltd.as of 31 May 2024335.30k1.09%
Mitsubishi UFJ Asset Management Co., Ltd.as of 07 Jun 2024137.60k0.45%
BlackRock Japan Co. Ltd.as of 06 Jun 202453.60k0.18%
Norges Bank Investment Managementas of 31 Dec 202342.60k0.14%
Dimensional Fund Advisors Ltd.as of 06 Jun 202439.88k0.13%
More ▼
Data from 30 Jun 2022 - 31 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.